Angiotensin II, oxidative stress and stem cell therapy: a matter of delicacy

Anton Roks

doi:10.1042/CS20150082

Angiotensin II, oxidative stress and stem cell therapy: a matter of delicacy

Anton Roks

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Abstract

Optimization of stem cell therapy after cardiovascular and renal injury depends on many factors, among which is stem cell donor health. The renin-angiotensin system (RAS) plays an important role in cardiovascular and renal homoeostasis and pathophysiology. It is becoming increasingly clear that the RAS affects the therapeutic performance of stem cells. In this issue of Clinical Science, Kankuri et al. dig deeper into the consequences of excessive angiotensin II signalling and reactive oxygen species (ROS) formation in the stem cell donor, applying a model of regenerative medicine after renal injury.

Original language	Undefined/Unknown
Pages (from-to)	749-750
Number of pages	2
Journal	Clinical Science
Volume	128
Issue number	11
DOIs	https://doi.org/10.1042/CS20150082
Publication status	Published - 2015

Access to Document

10.1042/CS20150082

http://hdl.handle.net/1765/86060

Cite this

@article{7461235655d149429f70de4694e68a9c,

title = "Angiotensin II, oxidative stress and stem cell therapy: a matter of delicacy",

abstract = "Optimization of stem cell therapy after cardiovascular and renal injury depends on many factors, among which is stem cell donor health. The renin-angiotensin system (RAS) plays an important role in cardiovascular and renal homoeostasis and pathophysiology. It is becoming increasingly clear that the RAS affects the therapeutic performance of stem cells. In this issue of Clinical Science, Kankuri et al. dig deeper into the consequences of excessive angiotensin II signalling and reactive oxygen species (ROS) formation in the stem cell donor, applying a model of regenerative medicine after renal injury.",

author = "Anton Roks",

year = "2015",

doi = "10.1042/CS20150082",

language = "Undefined/Unknown",

volume = "128",

pages = "749--750",

journal = "Clinical Science",

issn = "0143-5221",

publisher = "Portland Press, Ltd.",

number = "11",

}

TY - JOUR

T1 - Angiotensin II, oxidative stress and stem cell therapy: a matter of delicacy

AU - Roks, Anton

PY - 2015

Y1 - 2015

N2 - Optimization of stem cell therapy after cardiovascular and renal injury depends on many factors, among which is stem cell donor health. The renin-angiotensin system (RAS) plays an important role in cardiovascular and renal homoeostasis and pathophysiology. It is becoming increasingly clear that the RAS affects the therapeutic performance of stem cells. In this issue of Clinical Science, Kankuri et al. dig deeper into the consequences of excessive angiotensin II signalling and reactive oxygen species (ROS) formation in the stem cell donor, applying a model of regenerative medicine after renal injury.

AB - Optimization of stem cell therapy after cardiovascular and renal injury depends on many factors, among which is stem cell donor health. The renin-angiotensin system (RAS) plays an important role in cardiovascular and renal homoeostasis and pathophysiology. It is becoming increasingly clear that the RAS affects the therapeutic performance of stem cells. In this issue of Clinical Science, Kankuri et al. dig deeper into the consequences of excessive angiotensin II signalling and reactive oxygen species (ROS) formation in the stem cell donor, applying a model of regenerative medicine after renal injury.

U2 - 10.1042/CS20150082

DO - 10.1042/CS20150082

M3 - Article

SN - 0143-5221

VL - 128

SP - 749

EP - 750

JO - Clinical Science

JF - Clinical Science

IS - 11

ER -